Evidence map›Paper›PMID 36695636›Full record

ArticleGenes, chromosomes & cancer2023

A cloud-based resource for genome coordinate-based exploration and large-scale analysis of chromosome aberrations and gene fusions in cancer.

Janet Wang, Jeanne Zheng, Elaine E Lee, Boris Aguilar, John Phan, Kawther Abdilleh, Ronald C Taylor, William Longabaugh, Bertil Johansson, Fredrik Mertens and 3 more

Open access · greenAbstract read
In one paragraph

Article in Genes, chromosomes & cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Janet WangDepartment of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio, USA.ORCID 0000-0002-4411-0143
Jeanne ZhengSchool of Public Health, Brown University, Providence, Rhode Island, USA.
Elaine E LeeInstitute for Systems Biology, Seattle, Washington, USA.
Boris AguilarInstitute for Systems Biology, Seattle, Washington, USA.ORCID 0000-0002-9840-5908
John PhanGeneral Dynamics Information Technology, Rockville, Maryland, USA.
Kawther AbdillehPancreatic Cancer Action Network, Manhattan Beach, California, USA.
Ronald C TaylorDivision of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland, USA.ORCID 0000-0001-9777-9767
William LongabaughInstitute for Systems Biology, Seattle, Washington, USA.ORCID 0000-0002-4192-6315
Bertil JohanssonDivision of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Fredrik MertensDivision of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Felix MitelmanDivision of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
David PotGeneral Dynamics Information Technology, Rockville, Maryland, USA.ORCID 0000-0002-1480-9826
Thomas LaFramboiseDepartment of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio, USA.
Institute for Systems Biology · USLund University · SECase Western Reserve University · USGeneral Dynamics (United States) · USBrown University · USNational Cancer Institute · MYPancreatic Cancer Action Network · US

Funding

Mechanisms of lincDUSP Oncogenic Effects in Colon CancerR01CA217992 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI LAFRAMBOISE, THOMAS LOUIS · 2018 to 2023
$1.8M
Tools and Data for Bayesian Modeling of Mitochondrial Genome Dynamics in Human DiseaseR01LM013067 · NLM · CASE WESTERN RESERVE UNIVERSITY · PI BRYNJARSDOTTIR, JENNY, LAFRAMBOISE, THOMAS LOUIS · 2020 to 2024
$1.5M
Integrating Clues from the Somatic Genome in the Search for Rare Germline Cancer Susceptibility VariantsR21CA249138 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI LAFRAMBOISE, THOMAS LOUIS · 2020 to 2021
$414k
HHSNCI NIH HHS HHSN261201400008CNCI NIH HHS HHSN261201500003CNCI NIH HHS HHSN261201500003INCI NIH HHS R01 CA217992NCI NIH HHS R21 CA249138NIH HHS R01CA217992NIH HHS R01LM013067NIH HHS R21CA249138NLM NIH HHS R01 LM013067
6 · The paper itself

Abstract

Cytogenetic analysis provides important information on the genetic mechanisms of cancer. The Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer (Mitelman DB) is the largest catalog of acquired chromosome aberrations, presently comprising >70 000 cases across multiple cancer types. Although this resource has enabled the identification of chromosome abnormalities leading to specific cancers and cancer mechanisms, a large-scale, systematic analysis of these aberrations and their downstream implications has been difficult due to the lack of a standard, automated mapping from aberrations to genomic coordinates. We previously introduced CytoConverter as a tool that automates such conversions. CytoConverter has now been updated with improved interpretation of karyotypes and has been integrated with the Mitelman DB, providing a comprehensive mapping of the 70 000+ cases to genomic coordinates, as well as visualization of the frequencies of chromosomal gains and losses. Importantly, all CytoConverter-generated genomic coordinates are publicly available in Google BigQuery, a cloud-based data warehouse, facilitating data exploration and integration with other datasets hosted by the Institute for Systems Biology Cancer Gateway in the Cloud (ISB-CGC) Resource. We demonstrate the use of BigQuery for integrative analysis of Mitelman DB with other cancer datasets, including a comparison of the frequency of imbalances identified in Mitelman DB cases with those found in The Cancer Genome Atlas (TCGA) copy number datasets. This solution provides opportunities to leverage the power of cloud computing for low-cost, scalable, and integrated analysis of chromosome aberrations and gene fusions in cancer.

Indexed as

Cloud ComputingNeoplasmsChromosome AberrationsGene FusionHumansKaryotypingcloud-based analysiscytogeneticsgenomicsMitelman database

Identifiers

PMID36695636
PMCPMC10258157
OpenAlexW4317938489

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.